The discovery of specific cannabinoid receptors in the central nervous system has lead to much research to determine the main effects of these compounds.
Dr. Mark Jensen (photo), who is Professor and Vice Chair, Department of Rehabilitation Medicine at the University of Washington, in Seattle has published a series of studies on this topic.
 Perhaps you’ve heard that a company called Cannabis Science Inc. has offered Homeland Security Administration (HSA) Secretary Janet Napolitano to produce 1 million doses of its whole-cannabis lozenge, and provide them to HSA for distribution at cost. Continue reading Cannabis to treat H1N1 swine flu symptoms?→
Some researcher and editors must think that jargon-filled writing increases the relevance of their work. Here’s an abstract from a study where the word “shibboleth” was used.
Ten points if you know the definition of “shibboleth” without looking it up. Bonus points if you can use it in a sentence where no other simpler English-language word can be used.
That said. Here’s my summary of this spirituality study, with “shibboleth” deleted.
“Whenever a young patient without predisposing factors develops AF (atrial fibrillation), the possibility of marijuana smoking should be examined as a potential cause.”
Researchers from Italy and the US studied changes in psychological symptoms, reasoning, abuse, tolerability, quality of life, fatigue, and ability to control movement in patients with multiple sclerosis (MS) who had never before been exposed to cannabis. Continue reading Response to cannabis by non-smokers with MS→
Complementary and Alternative Medicine: Fair, Balanced, and to the Point